“due to effectiveness issues”. They did not work but were they safe?
Source: Occupy Corporatism, By Susanne Posel
GlaxoSmithKline (GSK) have ordered a recall of their 4 in 1 vaccine called Flulaval Quadrivalent Thimerosal “due to effectiveness issues”.
GSK said “the vaccine might cause more harm than good because it is not good enough to protect someone from the current flu strains present in the US.”
Flulaval “was designed” to protect against Type A and B and 2 other flu strains which makes it a quadrivalent vaccine – the new standard in inoculations.
GSK admitted in a statement “[we] cannot rule out prospective suboptional protection” for those who received Flulaval in early January of this year or later.
This information was disseminated in a letter to GSK clients such as wholesale distributors, pharmacies, government agencies and physicians in the US.
Because Flulaval is ineffective, 1.7 million doses are being recalled while GSK conducts testing on the product to prove efficiency.
View original post 65 more words